Target intelligence / Profile preview

Integrator complex subunit 4-like 2 pseudogene

Molecular classification
Pseudogene
01

Overview

The "Integrator complex subunit 4-like 2 pseudogene" (ENSG00000260900) is classified as a pseudogene, meaning it is a genomic DNA sequence similar to a known gene but generally considered non-functional due to mutations or lack of regulatory elements necessary for proper expression[4][6][8]. Pseudogenes do not code for functional proteins and are usually remnants of genes that have lost their protein-coding or regulatory capacity through evolutionary processes[4][6]. While some pseudogenes can be transcribed or exert regulatory effects, most are not considered direct targets for therapeutic intervention, and there is no evidence that "Integrator complex subunit 4-like 2 pseudogene" encodes for an active molecule or participates in the molecular processes attributed to the functional Integrator complex[4][6][2]. Because of this, it is not considered a receptor, enzyme, transporter, or any canonical therapeutic target class, and is generally of interest for genomics research or bioinformatics classifications, not drug targeting or clinical relevance[2][4][6]. Additional Notes: - The presence of "pseudogene" in the name and genomic databases signals that this entity is not a protein-coding gene and does not encode an active version of Integrator complex subunit 4 or participate in the Integrator complex's biological functions[4][6][8]. - Such pseudogenes may be included in gene databases (including Ensembl, GeneCards), but their annotation highlights their non-functional nature and distinguishes them from bona fide protein-coding targets[4][3][6]. Summary of error/incorrectness: This is not a druggable target or functional biomolecule, but rather a pseudogene—a non-functional gene copy—meaning it should not be used in contexts where an active target (such as receptor, enzyme, transporter, etc.) is required[4][6][8].

Beyond the preview

Go deeper on Integrator complex subunit 4-like 2 pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Integrator complex subunit 4-like 2 pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call